Independent Pharmacy · Buyer · Pre-LOI and confirmatory diligence
The independent pharmacy had plenty of sales. Losing one relationship could change everything.
Published · Reviewed by The Diligence Standard Team · Updated
A buyer considering the independent pharmacy was attracted by gross profit per script supported the initial case. Before accepting that story, the buyer needed to understand why payer concentration.
What was at stake
The buyer was not trying to win an argument. The question was whether the price, financing and responsibilities after closing still made sense if validate, monitor and assign ownership before relying on the acquisition case.
How the evidence changed the decision
The buyer needed the story and the records to agree. The review connected licenses/compliance, payroll and vendor/wholesaler terms, then traced the exceptions back to the operating claim instead of relying on another summary or screenshot.
The important moment was not a dramatic accusation. It was the point at which the records supported “Payer concentration required separate support” more clearly than “Gross profit per script supported the initial case.” The buyer could finally see what had changed and why it mattered.
Decision
The buyer could now decide whether to reprice the opportunity, change the terms, require additional proof or step away. The issue had a defined place in the decision instead of remaining a vague concern.
Evidence reviewed
- Licenses/compliance
- Payroll
- Vendor/wholesaler terms
- Rx system reports
The scenario uses the business-specific diligence framework to demonstrate a decision path. Actual findings and outcomes depend on the transaction records and qualified review.